Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Yalda Hekmatshoar, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, et al.
Life Sciences (2019) Vol. 233, pp. 116680-116680
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Yuxi Yi, Lijun Shen, Wei Shi, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 5, pp. 1329-1340
Open Access | Times Cited: 142
Radiotherapy and the gut microbiome: facts and fiction
Jing Liu, Chao Liu, Jinbo Yue
Radiation Oncology (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 139
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
Romain Villéger, Amélie Lopès, Guillaume Carrier, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4584-4584
Open Access | Times Cited: 94
Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways
Ling Wei, Xuesen Wen, Cory J. Xian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9474-9474
Open Access | Times Cited: 83
Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review
Michał Szczyrek, Paulina Bitkowska, Patryk Chunowski, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2217-2217
Open Access | Times Cited: 74
Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia
Julio Plaza‐Díaz, Marco Brandimonte-Hernández, Bricia López‐Plaza, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 246-246
Open Access | Times Cited: 1
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Justin Chau, Meeta Yadav, Ben Liu, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
Wenyu Li, Xiaorong Deng, Tingtao Chen
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
Modulating gut microbiota using nanotechnology to increase anticancer efficacy of the treatments
Abduladheem Turki Jalil, Shahad N. Thabit, Zaman Kareem Hanan, et al.
Macromolecular Research (2023) Vol. 31, Iss. 8, pp. 739-752
Closed Access | Times Cited: 17
Inosine, gut microbiota, and cancer immunometabolism
Elham Samami, Elahe Aleebrahim‐Dehkordi, Mehdi Mohebalizadeh, et al.
AJP Endocrinology and Metabolism (2022) Vol. 324, Iss. 1, pp. E1-E8
Closed Access | Times Cited: 26
Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment
Dongqin Zhou, Yongsheng Li
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 15
The role of the microbiome in drug resistance in gastrointestinal cancers
Ingrid Garajová, Rita Balsano, Heling Wang, et al.
Expert Review of Anticancer Therapy (2020) Vol. 21, Iss. 2, pp. 165-176
Open Access | Times Cited: 33
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer
Zhipeng Li, Xiyang Ke, Zuo Dan, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 48-48
Open Access | Times Cited: 22
Low-dose radiation ameliorates PM2.5-induced lung injury through non-canonical TLR1/TLR2-like receptor pathways modulated by Akkermansia muciniphila
Wang Li, Zhipeng Li, Huan He, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 289, pp. 117625-117625
Open Access
Compliant immune response of silk-based biomaterials broadens application in wound treatment
Zhiqiang Tian, Hong Chen, Ping Zhao
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Novel insights into the role of Clostridium novyi‑NT related combination bacteriolytic therapy in solid tumors (Review)
Feng Xu, Pan He, Chen Zeng, et al.
Oncology Letters (2020) Vol. 21, Iss. 2
Open Access | Times Cited: 28
The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review
Byeongsang Oh, Thomas Eade, Gillian Lamoury, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2353-2353
Open Access | Times Cited: 25
Microbiota as a New Target in Cancer Pathogenesis and Treatment
A. Algrafi, Aisha A Jamal, Dana M Ismaeel
Cureus (2023)
Open Access | Times Cited: 10
Gut microbiota; an overlooked effect of phosphate binders
Yalda Rahbar Saadat, Bahram Niknafs, Seyed Mahdi Hosseiniyan Khatibi, et al.
European Journal of Pharmacology (2019) Vol. 868, pp. 172892-172892
Closed Access | Times Cited: 23
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
Giovanni Vitale, Alessandra Dicitore, Luigi Barrea, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 511-525
Open Access | Times Cited: 23
Enzymatic Conversion of Mannan-Rich Plant Waste Biomass into Prebiotic Mannooligosaccharides
Nosipho Hlalukana, Mihle Magengelele, Samkelo Malgas, et al.
Foods (2021) Vol. 10, Iss. 9, pp. 2010-2010
Open Access | Times Cited: 20
The role of the gut microbiome in gastrointestinal cancers
Yachana Mishra, Abhigyan Ranjan, Vijay Mishra, et al.
Cellular Signalling (2023) Vol. 115, pp. 111013-111013
Open Access | Times Cited: 7
Dietary Recombinant Phycoerythrin Modulates the Gut Microbiota of H22 Tumor-Bearing Mice
Hongtao Qi, Ying Liu, Xin Qi, et al.
Marine Drugs (2019) Vol. 17, Iss. 12, pp. 665-665
Open Access | Times Cited: 22
Selenium-rich royal jelly inhibits hepatocellular carcinoma through PI3K/AKT and VEGF pathways in H22 tumor-bearing mice
Xuepeng Chi, Zhenguo Liu, Wei Wei, et al.
Food & Function (2021) Vol. 12, Iss. 19, pp. 9111-9127
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top